Suppr超能文献

关于新氨基糖苷类抗生素奈替米星的体外研究。

In vitro studies on netilmicin, a new aminoglycoside antibiotic.

作者信息

Stewart D, Bodey G P, LeBlanc B

出版信息

Antimicrob Agents Chemother. 1977 Jun;11(6):1017-20. doi: 10.1128/AAC.11.6.1017.

Abstract

Netilmicin, a semisynthetic derivative of sisomicin, was tested in vitro against 600 clinical bacterial isolates. At a concentration of 1.56 mug/ml, over 90% of gram-negative bacilli were inhibited. Netilmicin was substantially more active against isolates of Serratia marcescens and Enterobacter spp. than gentamicin, sisomicin, tobramycin, or amikacin. Isolates of Staphylococcus aureus (both penicillin G susceptible and resistant) were quite susceptible to netilmicin. Most isolates of Klebsiella spp. and Serratia spp. and some of the isolates of Pseudomonas aeruginosa that were resistant to gentamicin proved to be susceptible to netilmicin.

摘要

奈替米星是西索米星的半合成衍生物,对600株临床分离细菌进行了体外试验。在浓度为1.56微克/毫升时,超过90%的革兰氏阴性杆菌受到抑制。奈替米星对粘质沙雷氏菌和肠杆菌属菌株的活性明显高于庆大霉素、西索米星、妥布霉素或阿米卡星。金黄色葡萄球菌(对青霉素G敏感和耐药的菌株)对奈替米星相当敏感。大多数克雷伯菌属和沙雷氏菌属菌株以及一些对庆大霉素耐药的铜绿假单胞菌菌株对奈替米星敏感。

相似文献

本文引用的文献

1
Resistance of gram-negative bacilli to gentamicin.革兰氏阴性杆菌对庆大霉素的耐药性。
J Infect Dis. 1971 Dec;124 Suppl:S264-70. doi: 10.1093/infdis/124.supplement_1.s264.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验